Hospitalisation in patients with heart failure with preserved ejection fraction

Shane Nanayakkara; Hitesh C. Patel; David M. Kaye

doi:10.1177/1179546817751609

Hospitalisation in patients with heart failure with preserved ejection fraction

Shane Nanayakkara, Hitesh C. Patel, David M. Kaye

Research output: Contribution to journal › Article › Other › peer-review

20 Citations (Scopus)

Abstract

Heart failure is highly prevalent with more than 50% of cases being patients with a preserved ejection fraction (HFPEF), a figure that is projected to increase due to the changing risk factor landscape, in particular the ageing population. Overall mortality is similar to patients with heart failure with reduced ejection fraction (HFREF), as are the rates of hospitalisation. Patients with HFPEF have more comorbid conditions with fewer therapeutic options available. In this review, we explore the epidemiology of hospitalisation of HFPEF, the impact of current treatment modalities, and the potential of future therapies.

Original language	English
Number of pages	6
Journal	Clinical Medicine Insights: Cardiology
Volume	12
DOIs	https://doi.org/10.1177/1179546817751609
Publication status	Published - 1 Jan 2018
Externally published	Yes

Keywords

Admission
Heart failure
Mortality
Readmission
Treatment

Access to Document

10.1177/1179546817751609Licence: CC BY-NC

Cite this

@article{58afafc09d124e57a0209f8918a103ad,

title = "Hospitalisation in patients with heart failure with preserved ejection fraction",

abstract = "Heart failure is highly prevalent with more than 50% of cases being patients with a preserved ejection fraction (HFPEF), a figure that is projected to increase due to the changing risk factor landscape, in particular the ageing population. Overall mortality is similar to patients with heart failure with reduced ejection fraction (HFREF), as are the rates of hospitalisation. Patients with HFPEF have more comorbid conditions with fewer therapeutic options available. In this review, we explore the epidemiology of hospitalisation of HFPEF, the impact of current treatment modalities, and the potential of future therapies.",

keywords = "Admission, Heart failure, Mortality, Readmission, Treatment",

author = "Shane Nanayakkara and Patel, {Hitesh C.} and Kaye, {David M.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2018.",

year = "2018",

month = jan,

day = "1",

doi = "10.1177/1179546817751609",

language = "English",

volume = "12",

journal = "Clinical Medicine Insights: Cardiology",

issn = "1179-5468",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Hospitalisation in patients with heart failure with preserved ejection fraction

AU - Nanayakkara, Shane

AU - Patel, Hitesh C.

AU - Kaye, David M.

N1 - Publisher Copyright: © The Author(s) 2018.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Heart failure is highly prevalent with more than 50% of cases being patients with a preserved ejection fraction (HFPEF), a figure that is projected to increase due to the changing risk factor landscape, in particular the ageing population. Overall mortality is similar to patients with heart failure with reduced ejection fraction (HFREF), as are the rates of hospitalisation. Patients with HFPEF have more comorbid conditions with fewer therapeutic options available. In this review, we explore the epidemiology of hospitalisation of HFPEF, the impact of current treatment modalities, and the potential of future therapies.

AB - Heart failure is highly prevalent with more than 50% of cases being patients with a preserved ejection fraction (HFPEF), a figure that is projected to increase due to the changing risk factor landscape, in particular the ageing population. Overall mortality is similar to patients with heart failure with reduced ejection fraction (HFREF), as are the rates of hospitalisation. Patients with HFPEF have more comorbid conditions with fewer therapeutic options available. In this review, we explore the epidemiology of hospitalisation of HFPEF, the impact of current treatment modalities, and the potential of future therapies.

KW - Admission

KW - Heart failure

KW - Mortality

KW - Readmission

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85041423990&partnerID=8YFLogxK

U2 - 10.1177/1179546817751609

DO - 10.1177/1179546817751609

M3 - Article

C2 - 29343997

AN - SCOPUS:85041423990

SN - 1179-5468

VL - 12

JO - Clinical Medicine Insights: Cardiology

JF - Clinical Medicine Insights: Cardiology

ER -

Hospitalisation in patients with heart failure with preserved ejection fraction

Abstract

Keywords

Access to Document

Other files and links

Cite this